Atossa Genetics (ATOS) Reports Q2 Loss of $0.11
Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.
For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.
